[Observations on the treatment with nialamide of collateral mental manifestations in deaf-mute subjects]. 1961

O PIGNATARO

UI MeSH Term Description Entries
D009526 Nialamide An MAO inhibitor that is used as an antidepressive agent.
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D011600 Psychopharmacology The study of the effects of drugs on mental and behavioral activity.
D003638 Deafness A general term for the complete loss of the ability to hear from both ears. Deafness Permanent,Hearing Loss Permanent,Prelingual Deafness,Deaf Mutism,Deaf-Mutism,Deafness, Acquired,Hearing Loss, Complete,Hearing Loss, Extreme,Acquired Deafness,Complete Hearing Loss,Deafness, Prelingual,Extreme Hearing Loss,Permanent, Deafness,Permanent, Hearing Loss,Permanents, Deafness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

O PIGNATARO
October 1986, Morphologiai es igazsagugyi orvosi szemle,
O PIGNATARO
September 1977, Nursing times,
O PIGNATARO
January 1973, Kosmicheskaia biologiia i meditsina,
O PIGNATARO
January 1968, Acta oto-rino-laringologica ibero-americana,
O PIGNATARO
January 1967, Cirugia y cirujanos,
O PIGNATARO
January 1954, Revue d'oto-neuro-ophtalmologie,
O PIGNATARO
June 1963, The Indian journal of child health,
O PIGNATARO
June 1947, Proceedings of the staff meetings. Mayo Clinic,
O PIGNATARO
January 1956, Acta oto-rhino-laryngologica Belgica,
Copied contents to your clipboard!